• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血清素能激动剂治疗肥胖患者的疗效]

[Effectiveness of serotonergic agonists in the treatment of obese patients].

作者信息

Mendoza Espejo R, Díaz Pérez de Madrid J, Buitrago F

机构信息

Centro de Salud Universitario La Paz, Unidad Docente de Medicina de Familia y Comunitaria, Badajoz.

出版信息

Aten Primaria. 1995 Oct 15;16(6):364-6.

PMID:7488690
Abstract

OBJECTIVE

To compare the effectiveness of two interventions in the treatment of obese patients: hypocaloric diet and hypocaloric diet plus serotoninergic medication.

DESIGN

Randomised clinical trial.

SETTING

Primary Care. Out-patient Endocrinology clinic.

PATIENTS

The trial included 60 obese adults, assigned at random to two groups of 30 each. Both groups were comparable for sex, age, weight and Body Mass Index. Weight controls were performed at 2, 4 and 6 months.

RESULTS

There were no significant differences in weight losses at the times studied (2, 4 and 6 months) between the Control (Hypocaloric diet) and Study (Hypocaloric diet plus medication) groups. There were significant weight losses in both groups analysed between 2 and 4 months, with a Body Mass Index which went down from 36.2 to 34.12 and from 35.52 to 33.57 (p < 0.001) in the Control and Study groups, respectively.

CONCLUSIONS

No significant differences were observed in the results obtained for obese patients between a hypocaloric diet supplemented by serotoninergic medication and a hypocaloric diet.

摘要

目的

比较两种干预措施治疗肥胖患者的效果:低热量饮食和低热量饮食加血清素能药物。

设计

随机临床试验。

地点

初级保健。门诊内分泌诊所。

患者

该试验纳入60名肥胖成年人,随机分为两组,每组30人。两组在性别、年龄、体重和体重指数方面具有可比性。在2、4和6个月时进行体重控制。

结果

在研究的时间点(2、4和6个月),对照组(低热量饮食)和研究组(低热量饮食加药物)之间的体重减轻没有显著差异。两组在2至4个月期间均有显著体重减轻,对照组和研究组的体重指数分别从36.2降至34.12和从35.52降至33.57(p<0.001)。

结论

在肥胖患者中,补充血清素能药物的低热量饮食和低热量饮食在获得的结果上没有观察到显著差异。

相似文献

1
[Effectiveness of serotonergic agonists in the treatment of obese patients].[血清素能激动剂治疗肥胖患者的疗效]
Aten Primaria. 1995 Oct 15;16(6):364-6.
2
Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.低热量饮食联合西布曲明治疗对超重及肥胖多囊卵巢综合征女性激素和代谢特征的影响:一项随机、为期24周的研究
Int J Obes (Lond). 2008 Apr;32(4):692-9. doi: 10.1038/sj.ijo.0803777. Epub 2007 Dec 11.
3
[The treatment of the obese non-insulin-dependent patient with d-fenfluramine].[用右旋芬氟拉明治疗肥胖的非胰岛素依赖型患者]
Clin Ter. 1996 Apr;147(4):199-204.
4
Serotoninergic drug-induced weight loss in carbohydrate craving obese patients.5-羟色胺能药物诱导的碳水化合物渴望型肥胖患者体重减轻
Int J Obes Relat Metab Disord. 1996 Oct;20(10):917-20.
5
A comparative trial of different regimens of fenfluramine and phentermine in obesity.
Practitioner. 1973 Aug;211(262):232-6.
6
Balanced hypocaloric diet versus protein-sparing modified fast in the treatment of obesity: a comparative study.平衡低热量饮食与蛋白质节省型改良禁食治疗肥胖症的比较研究
Int J Obes. 1982;6(2):175-81.
7
[Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group].[右芬氟拉明在私人诊所长期治疗肥胖症中的耐受性和可接受性。ESIM 集团]
Rev Med Suisse Romande. 1997 Jan;117(1):19-24.
8
[Judicious use of anorectics].
Schweiz Rundsch Med Prax. 1991 Feb 5;80(6):116-7.
9
Prolonged use of a very low calorie diet (Cambridge diet) in massively obese patients attending an obesity clinic: safety, efficacy and additional benefit from dexfenfluramine.在一家肥胖症诊所就诊的极度肥胖患者中长期使用极低热量饮食(剑桥饮食法):安全性、疗效以及右芬氟拉明带来的额外益处。
Int J Obes. 1989;13 Suppl 2:91-3.
10
Appraisal of the clinical value of serotoninergic drugs.血清素能药物的临床价值评估。
Am J Clin Nutr. 1992 Jan;55(1 Suppl):189S-192S. doi: 10.1093/ajcn/55.1.189s.

引用本文的文献

1
Use of Fluoxetine to Reduce Weight in Adults with Overweight or Obesity: Abridged Republication of the Cochrane Systematic Review.氟西汀在超重或肥胖成年人中减肥的应用:Cochrane 系统评价的精简再版。
Obes Facts. 2022;15(4):473-486. doi: 10.1159/000524995. Epub 2022 Jun 2.
2
Fluoxetine for adults who are overweight or obese.氟西汀用于超重或肥胖的成年人。
Cochrane Database Syst Rev. 2019 Oct 15;10(10):CD011688. doi: 10.1002/14651858.CD011688.pub2.